摘要
本文作者报道肝动脉结扎（ＨＡＬ）加插管化疗（ＨＡＩ）治疗原发性肝癌２１例，其中１９例为经剖腹探查而不能切除者，２例为大肝癌切除术后行ＨＡＬ＋ＨＡＩ加门静脉插管化疗者。１９例不能切除的肝癌，其中ＨＡＬ＋ＨＡＩ加瘤内无水酒精注射１３例，ＨＡＬ＋ＨＡＩ加瘤体冷冻３例，ＨＡＬ＋ＨＡＩ加肿瘤周边微波固化１例，ＨＡＬ＋ＨＡＩ加门静脉插管化疗及瘤内无水酒精注射２例。经治疗，未切除的肿瘤缩小率为３８％，其中２例获二期手术切除。本组１例术后７天死于上消化道出血，２０例均获随访，平均生存１８个月。
21 cases of primary hepatocellalar carcinoma treated by
hepatic artery ligation(HAL)plus intu-bation chemotherapy(HAI)have been reported.19 cases of
them were unresectable,2 cases were large livercancer resceted+HAL + HAI +Portal Vein
intubation-chernotherapy. Of the l9 unresectable cases,13 treatedby HAL + HAI + absolute
aloohol injection into cancer,3 cases by HAL +HAI + refrigeration of cancer,1 caseby
HAL+HAI+Microwave solidification of tissues around the cancer,2 cases by HAL+HAI+portal
vein in-tubation chemoterapy+absolute alcohol injection into cancer. The unreaectable tumor
was getting smaller in therate of 38% after treatment.2 cases of them received subsequent
resection. 1 case died of upper alimentarycanal hemorrhage,20 cases were followed up,and
their survival time averaged 18 months.
出处
《实用癌症杂志》
1995年第3期177-179,共3页
The Practical Journal of Cancer
关键词
肝肿瘤
肝动脉结扎
药物疗法
Hepatoma
Hepatic artery
ligation(HAL)
Hepatic artery intubation(HAI)
Chemotherapy
